| PERIOD ENDING | 27-Mar-09 | 26-Dec-08 | 26-Sep-08 | 27-Jun-08 | | Total Revenue | 4,150,000 | 4,426,000 | 5,284,000 | 5,209,000 | | Cost of Revenue | 2,715,000 | 2,869,000 | 3,417,000 | 3,362,000 | | | Gross Profit | 1,435,000 | 1,557,000 | 1,867,000 | 1,847,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,200,000 | 1,140,000 | 1,301,000 | 1,227,000 | | Non Recurring | 2,789,000 | 4,000 | 137,000 | 44,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,554,000) | 413,000 | 429,000 | 576,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,000 | 16,000 | (8,000) | (241,000) | | Earnings Before Interest And Taxes | (2,536,000) | 429,000 | 421,000 | 335,000 | | Interest Expense | 78,000 | 73,000 | 73,000 | 91,000 | | Income Before Tax | (2,614,000) | 356,000 | 348,000 | 244,000 | | Income Tax Expense | (60,000) | 84,000 | 86,000 | 45,000 | | Minority Interest | (1,000) |
-
| 2,000 | (1,000) | | | | Net Income From Continuing Ops | (2,555,000) | 272,000 | 264,000 | 198,000 | | | Non-recurring Events | | Discontinued Operations | (12,000) | 5,000 | 170,000 | 278,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,567,000) | 277,000 | 434,000 | 476,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,567,000) | $277,000 | $434,000 | $476,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
